Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin T St Angelo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Blood|September 24, 2011
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responsesBrian C Betts, Erin T St Angelo, Michael Kennedy, et al.
Journal of Translational Medicine|July 11, 2013
Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapyDavid J Chung, Emanuela Romano, Katherine B Pronschinske, et al.
Blood|September 16, 2011
Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigenBrian C Betts, Omar Abdel-Wahab, Shane A Curran, et al.
Cancer Immunology Research|December 8, 2016
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 BlockadeShane A Curran, Justin A Shyer, Erin T St Angelo, et al.
Blood|April 19, 2012
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1Emanuela Romano, Jesse W Cotari, Rosa Barreira da Silva, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Blood|September 24, 2011
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responsesBrian C Betts, Erin T St Angelo, Michael Kennedy, et al.
Journal of Translational Medicine|July 11, 2013
Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapyDavid J Chung, Emanuela Romano, Katherine B Pronschinske, et al.
Blood|September 16, 2011
Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigenBrian C Betts, Omar Abdel-Wahab, Shane A Curran, et al.
Cancer Immunology Research|December 8, 2016
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 BlockadeShane A Curran, Justin A Shyer, Erin T St Angelo, et al.
Blood|April 19, 2012
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1Emanuela Romano, Jesse W Cotari, Rosa Barreira da Silva, et al.
Pageof 1